Xidong Ma

550 total citations
26 papers, 227 citations indexed

About

Xidong Ma is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Xidong Ma has authored 26 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Xidong Ma's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Xidong Ma is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Xidong Ma collaborates with scholars based in China, United States and Philippines. Xidong Ma's co-authors include Xinying Xue, Mei Xie, Chongchong Wu, Jialin Song, Xuelei Zang, Yuanyong Wang, Hui Deng, Xinying Xue, Zhiqiang Xue and Lei Pan and has published in prestigious journals such as Frontiers in Immunology, Medicine and Biomedicine & Pharmacotherapy.

In The Last Decade

Xidong Ma

25 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xidong Ma China 10 88 78 50 44 42 26 227
Lishu Zhao China 10 109 1.2× 87 1.1× 74 1.5× 23 0.5× 26 0.6× 30 235
Marta Abengózar Spain 7 101 1.1× 88 1.1× 39 0.8× 17 0.4× 57 1.4× 15 242
Şahin Laçin Türkiye 10 98 1.1× 38 0.5× 69 1.4× 53 1.2× 37 0.9× 37 242
Zhengfu He China 10 41 0.5× 85 1.1× 120 2.4× 45 1.0× 62 1.5× 43 288
Takayuki Shimamoto Japan 6 228 2.6× 129 1.7× 79 1.6× 22 0.5× 21 0.5× 8 293
Ross Taliano United States 8 57 0.6× 27 0.3× 44 0.9× 30 0.7× 38 0.9× 14 177
Anjui Wu United Kingdom 5 57 0.6× 92 1.2× 102 2.0× 58 1.3× 93 2.2× 9 250
Samantha Armstrong United States 10 144 1.6× 59 0.8× 82 1.6× 41 0.9× 59 1.4× 21 277
Emmanuelle Norguet France 8 110 1.3× 46 0.6× 53 1.1× 79 1.8× 28 0.7× 11 216
Senlin Zhu China 11 59 0.7× 63 0.8× 134 2.7× 27 0.6× 65 1.5× 31 321

Countries citing papers authored by Xidong Ma

Since Specialization
Citations

This map shows the geographic impact of Xidong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xidong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xidong Ma more than expected).

Fields of papers citing papers by Xidong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xidong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xidong Ma. The network helps show where Xidong Ma may publish in the future.

Co-authorship network of co-authors of Xidong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xidong Ma. A scholar is included among the top collaborators of Xidong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xidong Ma. Xidong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Yiran, Hui Deng, Jialin Song, et al.. (2024). Tertiary Lymphoid Structure in Tumor Microenvironment and Immunotherapy of Lung Cancer. Archivos de Bronconeumología. 60. S77–S85. 3 indexed citations
2.
3.
Wang, Junyu, Chaojie Yang, Junping Sun, et al.. (2024). Indirubin-3′-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo. Biomedicine & Pharmacotherapy. 174. 116558–116558. 4 indexed citations
4.
Zhang, Xin, Jie Yao, Mei Xie, et al.. (2024). Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis. International Immunopharmacology. 140. 112790–112790. 4 indexed citations
5.
Zhang, Xin, Mei Xie, Xidong Ma, et al.. (2024). Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer. Human Vaccines & Immunotherapeutics. 20(1). 2406063–2406063. 4 indexed citations
6.
Han, Jun, Jie Gao, Xidong Ma, et al.. (2024). Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations. The Clinical Respiratory Journal. 18(4). e13750–e13750. 2 indexed citations
7.
Xie, Mei, Jie Yao, Xidong Ma, et al.. (2024). Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies. Clinical and Translational Medicine. 14(3). e1613–e1613. 10 indexed citations
8.
Ma, Xidong, et al.. (2024). Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights. Trends in cancer. 10(10). 920–934. 6 indexed citations
9.
Xie, Mei, Jie Yao, Jialin Song, et al.. (2024). Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy. Frontiers in Immunology. 15. 1413067–1413067. 12 indexed citations
10.
Sun, Junping, Xidong Ma, Mingyue Zhang, et al.. (2023). Comparisons of lymphocytes profiles and inflammatory cytokines levels in blood of patients with differed severity of infection by human adenovirus type 7. BMC Infectious Diseases. 23(1). 174–174. 3 indexed citations
11.
Xue, Xinying, Mei Xie, Xidong Ma, et al.. (2023). Computed tomography (CT) characteristics and pathologic basis of ciliated muconodular papillary tumors of the lung. Quantitative Imaging in Medicine and Surgery. 13(7). 4339–4349. 2 indexed citations
12.
Pang, Li, Mei Xie, Xidong Ma, et al.. (2023). Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer. BMC Cancer. 23(1). 203–203. 15 indexed citations
13.
Ma, Xidong, Mei Xie, Zhiqiang Xue, et al.. (2022). HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Computers in Biology and Medicine. 151(Pt A). 106213–106213. 14 indexed citations
14.
Yao, Jie, Mei Xie, Xidong Ma, et al.. (2022). PIWI-interacting RNAs in cancer: Biogenesis, function, and clinical significance. Frontiers in Oncology. 12. 965684–965684. 16 indexed citations
15.
Meng, Yao, Jie Gao, Chongchong Wu, et al.. (2022). The prognosis of different types of pleural tags based on radiologic-pathologic comparison. BMC Cancer. 22(1). 919–919. 4 indexed citations
16.
Xie, Mei, Jie Gao, Xidong Ma, et al.. (2022). Consolidation radiographic morphology can be an indicator of the pathological basis and prognosis of partially solid nodules. BMC Pulmonary Medicine. 22(1). 369–369. 5 indexed citations
17.
Zhao, Shuo, Chongchong Wu, Jie Gao, et al.. (2021). Pulmonary mucosa‐associated lymphoid tissue lymphoma: CT findings and pathological basis. Journal of Surgical Oncology. 123(5). 1336–1344. 9 indexed citations
18.
Zang, Xuelei, Chongchong Wu, Xiaoli Sun, et al.. (2021). Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis. BMC Cancer. 21(1). 634–634. 21 indexed citations
19.
Xue, Xinying, Xuelei Zang, Yuxia Liu, et al.. (2020). Independent risk factors for lymph node metastasis in 2623 patients with Non–Small cell lung cancer. Surgical Oncology. 34. 256–260. 8 indexed citations
20.
Xue, Xinying, Chen Wang, Zhiqiang Xue, et al.. (2020). Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma. Acta Biochimica et Biophysica Sinica. 52(3). 281–293. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lishu Zhao Breakdown of academic impact, for papers by Marta Abengózar Breakdown of academic impact, for papers by Şahin Laçin Breakdown of academic impact, for papers by Zhengfu He Breakdown of academic impact, for papers by Takayuki Shimamoto Breakdown of academic impact, for papers by Ross Taliano Breakdown of academic impact, for papers by Anjui Wu Breakdown of academic impact, for papers by Samantha Armstrong Breakdown of academic impact, for papers by Emmanuelle Norguet Breakdown of academic impact, for papers by Senlin Zhu
Rankless by CCL
2026